Catalent to Purchase BMS Mfg. Facility, iBio Inks First Fill-Finish Services Agreement, and More in Today's CP Direct!
 Trouble viewing this email? Read it online
Follow us on:       
Sponsored by Emergent
June 19, 2019
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by Jones Packaging

Catalent to Purchase BMS Mfg. Facility in Anagni, Italy
Catalent will continue to manufacture BMS products while offering access to sterile biologics fill/finish and oral solids manufacturing and packaging platforms

iBio Inks First Fill-Finish Services Agreement
To provide cGMP sterile fill-finish for the customer’s investigational therapy for late-stage clinical trial

Experience New Benchmarks in UHPLC Analysis
Incorporating Analytical Intelligence, utilizing the Internet of Things, and featuring the most advanced performance features, including the fastest sampling speeds, highest cooling efficiency, and co-injection automation, Shimadzu’s new compact Nexera UHPLC enables smarter, more efficient workflows, higher productivity, and maximum reliability.
Learn More >>

Gamida Cell and Lonza to Manufacture Omidubicel
Strategic manufacturing agreement is signed for the future commercial production of Phase 3 investigational advanced cell therapy

Sanofi and Google to Develop Innovation Lab
Virtual healthcare Innovation Lab aims to radically transform how future medicines and health services are delivered

GlobePharma introduces the SIFT-N-BLEND™powder blender
The new technology features an interchangeable built-in screening mechanism that eliminates the need to pre-screen any materials.
Learn More >>

Gemini Adds to Executive Leadership Team
Donald O’Neil to lead commercial efforts and Brendan Lucey to head up business development

Colorcon, Inc. Introduces one-step Opadry Enteric
A fully formulated one-step system aims to enhance enteric performance for hydro-alcoholic applications

WEBINAR: Stability Testing as a Quality Control Measure: Optimizing the Process throughout the Product Lifecycle
Join Contract Pharma and Frontage Labs on June 25th at 10:00 AM EST as we discuss the purpose, scope, and type of stability testing required at each phase of product development.
Register Now >>

GSK Partners with University of California for Genomic Research
New ‘Laboratory for Genomics Research’ unites CRISPR pioneers with industry expertise to help unravel mysteries of the human genome

Otsuka Chemical Enters API Business
Acquires cefixime business from Astellas

June 2019

Latest Issue Check out the feature
from the latest issue.


Polymers for Drug-Device Combination Products
Released by: Lubrizol LifeSciences
Several polymers are available for drug-device combination product developers, many that meet necessary regulatory requirements.

Microsite Spotlight

Ascendia Pharmaceuticals
Ascendia is a privately-held, specialty CDMO. We provide feefor-service formulation development for companies ranging from biotechs, generics, big pharma, animal health, virtual/ start-ups, and academic institutions.


Need a job? Need to fill a job? There's a lot of interest in's Job Bank
Find out about new employment opportunities and visit's Job Bank today! To find out how to add a job, contact Gary Durr, or Damaris Kope,

We hope you enjoyed this edition of Contract Pharma Direct's Newsletter

You are receiving this message because you opted in at To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address ( to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Montvale, NJ 07645 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2019 Contract Pharma All rights reserved.